New technologies to be featured at American Association of Respiratory Care (AARC) Congress, booth #1023
SAN DIEGO, Nov. 4, 2011 /PRNewswire/ -- CareFusion today announced the CareFusion Ventilation System, combining its industry leading ventilators with new interoperability and analytics software to better address clinical and operational challenges in patient care.
The CareFusion Ventilation System includes the company's AVEA®, VELA® and EnVeTM ventilators and adds two new applications:
- CareFusion Respiratory Documentation Application: A handheld, positive patient ID application that automates the collection of ventilator documentation data at the point of care, and then wirelessly transmits it to hospital's electronic medical records (EMR) system. Examples of documentation data include ventilator status, vital signs, breath sounds and clinical observations. This application enables more accurate and efficient documentation of therapy compared to manually entering the information into a computer.
- CareFusion Knowledge Portal for ventilator therapy: An analytics and reporting tool that measures clinical and process variability in ventilator therapy, and provides hospitals actionable information to help clinicians improve patient care. The initial reporting capabilities focus on ventilator weaning and notifications on important patient trends to measure compliance with best practices. The Knowledge Portal for ventilator therapy is anticipated to be released later this month.
"Our focus is on delivering the safest and most effective care for our ventilated patients," said Michael Muth, director of respiratory at Good Samaritan Hospital in Los Angeles, which is the first limited release site for the new applications. "We've been impressed so far with how the CareFusion Ventilation System has helped us establish a better, more efficient workflow, so our respiratory therapists can spend more time with patients and less time on paperwork."
Kevin Ketzel, general manager for Respiratory Technologies at CareFusion said, "It costs $4,900 per day to treat some of the most difficult-to-wean ventilator patients, and our customers are seeing decreasing reimbursement for these cases. Our new ventilation system helps address these pressures and provides capabilities to help our customers improve the quality of patient care, while reducing costs."
CareFusion is featuring the new ventilation system, along with other respiratory solutions, at the 57th AARC International Respiratory Congress being held Nov. 5-8 in Tampa, Fla. Visit CareFusion at booth #1023.
The CareFusion Knowledge Portal for ventilator therapy is currently an unreleased product and the company may not make it available for commercial sale.
CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops market-leading technologies including Alaris® infusion pumps, Pyxis® automated dispensing and patient identification systems, AVEA®, AirLife™ and LTV® series ventilation and respiratory products, ChloraPrep® products, MedMined™ services for data mining surveillance, Nicolet™ neurological monitoring and diagnostic products, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 14,000 people across its global operations. More information may be found at www.carefusion.com.
SOURCE CareFusion Corp.